Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-046252

Chief Commercial Officer bought 1,500 shares at $5.48 ($8,213)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-08-15 Purchase : show line 1 in the form +1,500 $5.48 $8,213 9,000 D
Open-market purchases · 1,500 sh · avg $5.48 · $8,213
Loading xslF345X03/doc4.xml…